Imagine a device so small, it fits in the palm of your hand, yet has the power to transform mental health diagnostics and treatments. Meet iBrain™, a groundbreaking innovation that is about to change the game for neurotechnology! This tiny gadget, roughly the size of two quarters, boasts double the battery life, quadruples the channels, and comes equipped with sixteen endpoints that hunt for critical biomarkers related to various neurological conditions.

From ALS to PTSD, this revolutionary tool is designed to monitor responses to drugs and provide neurofeedback for a range of disorders like Autism, Brain Cancer, Dementia, and even Traumatic Brain Injury. Best of all, it will soon be available for both research and consumer use, priced at a cost comparable to your daily vegan latte—complete with two monthly consultations with neurologists or dedicated concierges.

Dr. Low, a pioneer in neurotechnology and the brain behind NeuroVigil, passionately recalls the early days of his journey when terms like ‘neurotechnology’ were met with skepticism. Reflecting on his voyage, he describes it as navigating through a starless night, now illuminated by the promise of this astonishing device. “It is both a great honor and an awesome responsibility,” he shares, recognizing the potential of iBrain™ to revolutionize lives.

Having founded NeuroVigil during his PhD journey at the Salk Institute in 2007, Dr. Low has emerged as a respected figure in the field. His accolades include recognition by MIT Technology Review as one of the Top Young Innovators—an elite group that includes the founders of tech giants like Google and Facebook. The company’s valuation has previously outstripped that of these trailblazers, with its Series B valuation skyrocketing to twelve times that of Facebook.

Furthermore, with a treasure trove of patents and accolades like being named one of the Top 10 Most Innovative Companies in Health Care by Fast Company, it’s clear that NeuroVigil is on the cutting edge. The New York Times heralds iBrain™ as “an innovation that will change your tomorrow.” With such high expectations and potential, the world is eagerly awaiting the dawn of a new era in mental health.